[Intravitreal application of triamcinolone--our experiences].
OBJECTIVE
To show the results of intravitreal application of triamcinolone used as a primary or adjuvant therapy.


METHODS
We analyzed 48 patients with different ocular disorders: exudative age related macular degeneration, diabetic retinopathy, or central retinal vein occlusion. We analyzed color fundus photography, visual acuity, fluorescein angiography and complications of intravitreal triamcinolone application.


RESULTS
There was a marked reduction of macular edema in 70% of patients verified on fluorescein angiography. Visual acuity improved in 62% of patients. The most common complication was transient rise in intraocular pressure. There was no case of endophthalmitis.


CONCLUSIONS
Intravitreal application of triamcinolone is relatively safe and efficacious in selected patiens with different ocular disorders.
Konjević Pernar
Slavica
S
Klinika za ocne bolesti, Klinicka bolnica Sestre milosrdnice, Zagreb, Hrvatska.
Vatavuk
Zoran
Z
Bencić
Goran
G
Pentz
Ante
A
Mandić
Zdravko
Z
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D003930:Diabetic Retinopathy / Q000188:drug therapy*; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D007267:Injections; D008268:Macular Degeneration / Q000188:drug therapy*; D008297:Male; D012170:Retinal Vein Occlusion / Q000188:drug therapy*; D014222:Triamcinolone Acetonide / Q000008:administration & dosage*; D014822:Vitreous Body
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D014222:Triamcinolone Acetonide